Kate Hermans Ambrx Biopharma Inc. (AMAM) insider trading activity
Kate Hermans is Director of Ambrx Biopharma Inc.. Currently has a direct ownership of 85,000 shares of AMAM, which is worth approximately $2.38 Million. The most recent transaction as insider was on Jun 07, 2023, when has been sold 85,000 shares (Ordinary Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
85K
0%
3M change
0%
12M change
Total Value Held
$2.38 Million
Kate Hermans Transaction History
Also insider at
KH
Kate Hermans
Director
La Jolla, CA